The primary mission of the Human Tissue Acquisition and Pathology Shared Resource (HTAP) is to provide Vanderbilt Cancer Center investigators with access to human tissue for the purpose of carrying out translational research. There are two main components to this Shared Resource: 1) human tissue procurement, and 2) research histology. Each of these components provides critical reagents that allow basic and applied scientific investigations of human tissues with appropriate attention to ethical concerns. Our mission is facilitated by our highly experienced personnel and a close working relationship with the Anatomic Pathology Division of the Department of Pathology. Dr. Jensen has an NCI-funded program of investigation and is an attending physician in Pathology. Ms. Newsom-Johnson worked in the Department of Pathology for over 15 years. Therefore the personnel that staff the Shared Resource have a keen appreciation of the needs of cancer researchers and are very knowledgeable concerning the need for appropriate evaluation of clinical specimens. The HTAP Shared Resource has experienced substantial growth over the last three years and has served 42 different investigators 23 of whom are Cancer Center members. During this period we have provided approximately 24,000 slides, 3,000 blocks, and provided 2,000 frozen specimens to the Vanderbilt research community. We expect continued growth for the next several years and we are in the process of adding additional personnel to keep up with the increased demand for our services. Also, due to the expressed interests from a number of Cancer Center investigators we are adding a microdissection service to the Shared Resource that will enable investigators to carefully separate tumor and normal cells for genetic and biochemical analysis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA068485-07
Application #
6652746
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2002-09-01
Project End
2003-08-31
Budget Start
Budget End
Support Year
7
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37203
Pannala, Venkat R; Wall, Martha L; Estes, Shanea K et al. (2018) Metabolic network-based predictions of toxicant-induced metabolite changes in the laboratory rat. Sci Rep 8:11678
Zhao, Shilin; Li, Chung-I; Guo, Yan et al. (2018) RnaSeqSampleSize: real data based sample size estimation for RNA sequencing. BMC Bioinformatics 19:191
Croessmann, Sarah; Sheehan, Jonathan H; Lee, Kyung-Min et al. (2018) PIK3CA C2 Domain Deletions Hyperactivate Phosphoinositide 3-kinase (PI3K), Generate Oncogene Dependence, and Are Exquisitely Sensitive to PI3K? Inhibitors. Clin Cancer Res 24:1426-1435
Doxie, Deon B; Greenplate, Allison R; Gandelman, Jocelyn S et al. (2018) BRAF and MEK inhibitor therapy eliminates Nestin-expressing melanoma cells in human tumors. Pigment Cell Melanoma Res 31:708-719
Salisbury-Ruf, Christi T; Bertram, Clinton C; Vergeade, Aurelia et al. (2018) Bid maintains mitochondrial cristae structure and function and protects against cardiac disease in an integrative genomics study. Elife 7:
Laroumanie, Fanny; Korneva, Arina; Bersi, Matthew R et al. (2018) LNK deficiency promotes acute aortic dissection and rupture. JCI Insight 3:
Burns, Michael C; Howes, Jennifer E; Sun, Qi et al. (2018) High-throughput screening identifies small molecules that bind to the RAS:SOS:RAS complex and perturb RAS signaling. Anal Biochem 548:44-52
Phelps, Hannah M; Al-Jadiry, Mazin F; Corbitt, Natasha M et al. (2018) Molecular and epidemiologic characterization of Wilms tumor from Baghdad, Iraq. World J Pediatr 14:585-593
Liu, Qi; Herring, Charles A; Sheng, Quanhu et al. (2018) Quantitative assessment of cell population diversity in single-cell landscapes. PLoS Biol 16:e2006687
Almodovar, Karinna; Iams, Wade T; Meador, Catherine B et al. (2018) Longitudinal Cell-Free DNA Analysis in Patients with Small Cell Lung Cancer Reveals Dynamic Insights into Treatment Efficacy and Disease Relapse. J Thorac Oncol 13:112-123

Showing the most recent 10 out of 2462 publications